E-MTAB-7845
Predicting response to vedolizumab therapy using mucosal transcriptomics in IBD patients
In this study we wanted to identify baseline predictors of successful vedolizumab therapy in patients with inflammatory bowel disease.
In this study we wanted to identify baseline predictors of successful vedolizumab therapy in patients with inflammatory bowel disease.